Psilocybin Therapy Shows Promise for Binge Eating Disorder
The findings add to growing evidence that psychedelics may treat conditions long resistant to conventional approaches.
Read More
Psilocybin Offers Rapid Relief for Cancer Patients Battling Depression
For patients facing terminal illness, time is precious. Traditional antidepressants can take six to twelve weeks to work. A new analysis suggests psilocybin may offer a faster path to relief.
Read More
Texas Invests $50 Million in Ibogaine Research for Addiction Treatment
The University of Texas Medical Branch just received a $50 million grant to study ibogaine, a plant based psychoactive compound.
Read More
New Mexico Accelerates Psilocybin Therapy Program, Beating Original Deadline by a Year
State health officials announced plans to launch the medical psilocybin program by December 2026. That is a full year ahead of schedule.
Read More
Why Timing Matters: The Science Behind Scheduling Psychotherapy After Ketamine
New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?
Read More
Congressional Psychedelics Report Card: Who Supports and Opposes Legalization
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
Low Dose Ketamine Restores Consciousness in 45 Minutes: A Surprising Case Report
A 66 year old woman arrived at the hospital confused and disoriented. What happened next challenged conventional thinking about ketamine.
Read More
Bipartisan Bill Would Let Doctors Administer MDMA and Psilocybin to Seriously Ill Patients
The Freedom to Heal Act would allow doctors to legally administer Schedule I drugs like MDMA and psilocybin to very ill patients.
Read More
Doctor Receives 30 Months in Matthew Perry Ketamine Case
Dr. Salvador Plasencia became the first person sentenced in connection with actor Matthew Perry's 2023 ketamine overdose death.
Read More
Survey: 1.6 Million Americans Received Ketamine Treatment Last Year
A major new survey found that 1.6 million American adults received ketamine treatment in a supervised medical facility last year.
Read More